Stacey Ivanchuk is a driven and diverse individual with a strong passion for team building and creative problem-solving. Holding a Ph.D. in molecular cancer biology from the University of Toronto and an M.Sc. in cancer genetics from Queen's University, Ivanchuk has had a successful career in the scientific industry. Ivanchuk began working with Toronto Innovation Acceleration Partners (TIAP), where she helped streamline intellectual property positions for startup companies such as Encycle Therapeutics, ChipCare, BresoTec, and OtoSim. With expertise in IP portfolio management and strategy, Ivanchuk has also worked as a scientific advisor at Norton Rose Fulbright and led IP strategy development at Topigen Pharmaceuticals. Her previous experience has led to her most recent role as the Director of Alliance Management at BlueRock Therapeutics, where she continues to utilize her expertise and experience to advance research opportunities.